Integrated and total HIV-1 DNA can predict quantitative viral outgrowth in patients on long-term ART

by W. De Spiegelaere, M. Kiselinova, M.J. Buzon, E. Malatinkova, M. Lichterfeld, L. Vandekerckhove
Published 2015-12-01

O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR

by S. Rutsaert, W. Trypsteen, C. Van Hecke, M.A. De Scheerder, M. Kiselinova, K. Vervisch, W. De Spiegelaere, L. Vandekerckhove
Published 2016-09-01

Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs

by S. Kinloch, E. Malatinkova, W. De Spiegelaere, P. Bonczkowsk, M. Kiselinova, K. Vervisch, W. Trypsteen, M. Johnson, D. de Looze, L. Vandekerckhove
Published 2015-12-01

O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?

by P. Pannus, P. Adams, E. Willems, L. Heyndrickx, M. Van Frankenhuijsen, E. Florence, M. Kiselinova, S. Rutsaert, K. Vervisch, W. Despiegelaere, C. Devaux, L. Vandekerckhove, G. Vanham
Published 2017-09-01